Canada markets closed

CVS Health Corporation (CVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
85.77-0.41 (-0.48%)
At close: 04:00PM EST
85.89 +0.12 (+0.14%)
After hours: 07:59PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.68
52-Week Change 3-21.61%
S&P500 52-Week Change 3-7.75%
52 Week High 3111.25
52 Week Low 384.82
50-Day Moving Average 393.99
200-Day Moving Average 396.33

Share Statistics

Avg Vol (3 month) 37.23M
Avg Vol (10 day) 310.72M
Shares Outstanding 51.31B
Implied Shares Outstanding 6N/A
Float 81.31B
% Held by Insiders 10.38%
% Held by Institutions 180.82%
Shares Short (Jan 12, 2023) 425.31M
Short Ratio (Jan 12, 2023) 43.55
Short % of Float (Jan 12, 2023) 41.93%
Short % of Shares Outstanding (Jan 12, 2023) 41.93%
Shares Short (prior month Dec 14, 2022) 414.08M

Dividends & Splits

Forward Annual Dividend Rate 42.42
Forward Annual Dividend Yield 42.81%
Trailing Annual Dividend Rate 32.15
Trailing Annual Dividend Yield 32.49%
5 Year Average Dividend Yield 42.80
Payout Ratio 490.72%
Dividend Date 3Jan 31, 2023
Ex-Dividend Date 4Jan 18, 2023
Last Split Factor 22:1
Last Split Date 3Jun 06, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 1.00%
Operating Margin (ttm)4.70%

Management Effectiveness

Return on Assets (ttm)3.97%
Return on Equity (ttm)4.34%

Income Statement

Revenue (ttm)314.34B
Revenue Per Share (ttm)239.00
Quarterly Revenue Growth (yoy)10.10%
Gross Profit (ttm)50.85B
Net Income Avi to Common (ttm)3.15B
Diluted EPS (ttm)2.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.99B
Total Cash Per Share (mrq)15.21
Total Debt (mrq)71.07B
Total Debt/Equity (mrq)100.09
Current Ratio (mrq)0.94
Book Value Per Share (mrq)53.75

Cash Flow Statement

Operating Cash Flow (ttm)22.13B
Levered Free Cash Flow (ttm)17.6B